microneedling-does-it-still-have-a-place > 공지사항

본문 바로가기
도매로팜 엑셀 대량발주
쇼핑몰 전체검색
  • 회원가입

    로그인

    다양한 서비스와 이벤트 혜택을 누리실 수 있습니다.

microneedling-does-it-still-have-a-place

페이지 정보

profile_image
작성자 Sylvester Ziegl…
댓글 0건 조회 2회 작성일 26-08-20 23:06

본문

Microneedling — Does It Still Have a Place?


One of the oldest techniques in modern aesthetic medicine is also one of the most misunderstood. Here is an honest clinical account of what microneedling actually does, what the science says about topical penetration, and where the procedure sits in a contemporary treatment landscape.


A technique with a longer history than its current marketing suggests


Microneedling is frequently presented as though it were a relatively recent innovation; a product of the and energy-based treatment era. In fact, the concept of using controlled skin injury to stimulate collagen predates most of the treatments that now share its clinical space.


The modern dermaroller, the device that brought the technique into widespread aesthetic practice was developed in the mid-1990s by Dr. Desmond Fernandes, a South African plastic surgeon, who observed that controlled needling of the skin produced progressive improvements in texture, firmness, and scar architecture. His observations were clinically astute, and the biological mechanism he was exploiting has since been characterised in considerable scientific detail.


What microneedling actually does


Microneedling, formally termed percutaneous collagen induction therapy, works by creating thousands of controlled micro-injuries in the epidermis and upper dermis using fine needles. These micro-injuries trigger the skin's intrinsic wound healing cascade, a precisely orchestrated biological sequence that unfolds in three phases: an initial inflammatory response in the first 24 to 72 hours, a proliferative phase lasting days three to fourteen during which new collagen and elastin fibres begin forming, and a remodelling phase that continues for weeks to months as the new collagen matures and reorganises


The main physiological mechanisms associated with microneedling are collagen and elastin production, transient increases in OmniJuve – Skin Rejuvenation permeability, and improved skin barrier post-treatment. As the wound repair process is initiated, fibroblasts migrate to the wounded area to initiate collagen and elastin production, to improved firmness and elasticity of the healed epidermis.


Improved vascularity enhances the delivery of nutrients and growth factors to the tissue, contributing to the overall improvement in skin quality that goes beyond what collagen stimulation alone would produce.


Is Needle depth important and what it determines


The depth to which needles determines which tissue layer is targeted and, consequently, what clinical effect is produced


0.5mm, needles the epidermis and superficial dermis, primarily enhancing penetration and improving surface skin quality.


At 0.5 to 1.5mm, needles reach the papillary dermis and initiate meaningful collagen induction.


At 1.5 to 2.5mm, the reticular dermis is targeted, producing the most significant stimulation, but with the most significant post-procedure recovery requirement.


This depth-effect relationship has important clinical implications. A 0.3mm dermaroller used at home bears little resemblance to a 1.5mm professional treatment in its biological effects, however similar the devices may look.


The marketing that conflates the two or that implies home microneedling produces the same clinical result as a professional treatment is not serving patients honestly.


From manual to motorised — and why it matters


The original dermaroller relies on manual pressure and a rolling technique to drive needles to the correct depth consistently. The shift to motorised microneedling pens in which needles oscillate at high speed and penetrate vertically rather than at an angle represented a clinical advance.


Vertical needle penetration reduces the epidermal tearing that can occur with motion, produces more consistent depth control across different areas and skin thicknesses, and allows depth and speed to be adjusted within a single treatment session.


The motorised pen is now the professional standard for good clinical reasons, and those reasons go beyond marketing preference. It is for these sound reasons that at the Cosmetic Doctors Company in Esher, Surrey we use the


The topical penetration question — and its surprising answer


One of the most clinically discussed aspects of is its to enhance the penetration of topically applied actives.


The logic is intuitive: create microchannels through the stratum corneum, apply beneficial ingredients, and those ingredients will penetrate more deeply than they could intact skin.


This logic is correct in principle. The reality is more nuanced and in one important respect, genuinely surprising.


Microneedled skin sites recover barrier properties within approximately two hours. Hence the effective penetration window for topically applied compounds is considerably shorter than most post-procedure protocols acknowledge


More significantly, topical agent applied immediately before microneedling penetrated deeper compared to agent applied afterward at one and three hours, with microneedling demonstrating lateral extension beyond microchannels with increased penetration over time. This finding, that pre-application may produce deeper penetration than post-application, challenges the standard clinical assumption that topicals should be applied after needling and raises important questions about the optimal sequencing of application in a microneedling protocol


What topical serums are worth using and when


Given the penetration kinetics described above, the post-microneedling topical strategy deserves more clinical thought than it typically receives.


The ingredients with the strongest rationale for post-procedure are those with a documented effect on wound healing and barrier recovery: hyaluronic acid for surface hydration and tissue support, growth factors and PDRN for wound acceleration, and ceramide-based formulations to support barrier recovery as the microchannels reseal.


The trendy topicals examined in namely complexes, peptide cocktails, and NAD precursors may have a more defensible delivery window via post-microneedling application than via standard intact-skin topical use. The questions about their biological activity after formulation, and about whether they are optimally sized for microchannel penetration, remain.


The clinical indications where microneedling genuinely excels


The evidence base for microneedling is strongest in several specific indications.


Acne scarringparticularly rolling and boxcar scars has a well-evidenced response to multiple microneedling sessions, with histological evidence of genuine dermal and clinical improvement in scar depth and texture.


Skin quality improvement in texture, tone, pore appearance, and the overall quality of the dermal matrix is consistently demonstrated across a broad range of studies. Microneedling has been widely employed in cosmetic applications for acne scar treatment, skin rejuvenation, hair loss, melasma, and skin cancer, with the micro-channels formed facilitating delivery of cosmetic agents while stimulating collagen and elastin production through the wound-healing cascade.


The evidence for stretch marks and for presentations of hyperpigmentation is more variable but clinically credible. The evidence for hair loss, particularly androgenetic alopecia in combination with topical minoxidil, is growing and genuinely interesting.


Where microneedling sits in a contemporary treatment landscape


Standard microneedling produces genuine and well-evidenced collagen induction without the thermal component that energy-based devices introduce.


For patients with darker skin types, where the risk of post-inflammatory with energy-based treatments is a meaningful clinical consideration, microneedling offers a safer path to collagen stimulation. Its cost profile, both for the clinic and the patient, makes a series of more accessible than energy-based alternatives. And its to enhance topical penetration, properly understood and properly managed, adds a clinically useful dimension that energy-based devices cannot replicate in the same way.


Summary


Microneedling has a well-established, well-evidenced clinical role that has not been displaced by newer technologies. It works a mechanism that is precisely characterised and consistently reproducible.


The clinical results in appropriate indications i.e. acne scarring, skin quality and collagen stimulation are real, meaningful, and durable when a proper series of treatments is .


The topical penetration dimension is clinically important but more nuanced than standard protocols acknowledge. The technique that Dr. developed in the 1990s remains, in 2025, a genuinely useful and scientifically credible tool in the aesthetic medicine repertoire. Not everything that has come since has earned the right to displace it.


The views expressed in Clinical Perspectives are the Dr Forrester’s own and reflect his personal and professional experience in aesthetic medicine.


References


L et al. Physiological Mechanisms and Therapeutic Applications of Microneedling: A Narrative Review. Cureus. 2025. 


Recent Advances in Microneedling-Assisted Cosmetic ApplicationsCosmetics. 2024;11(2):51. 


Ogunjimi AT et al. Micropore closure time is longer following microneedle application to skin of color. Scientific Reports. 2020. 


Factors Depth of Penetration in Microneedling and Drug Delivery: The Importance of Timing of TopicalPubMed. 2020. 


Kinetics of Skin Resealing After Insertion of Microneedles in Human SubjectsPMC. 2011. 


Carver S et al. Microneedling versus microcoring: A review of percutaneous induction for the face and neck. Journal of Cosmetic Dermatology. 2024;23:1541–1550. 



Does Drinking More Water Actually Hydrate Your Skin?


The Trendy Topicals — Growth Factors, Exosomes, Peptides, NAD, PDRN, and the Rest


6 Esher Park Avenue
Esher, Surrey KT10 9NP


Tel: ‬
Tel: ‭ ‬


© 2026
The Cosmetic Doctors
Company
Ltd
Company no.

댓글목록

등록된 댓글이 없습니다.

장바구니

오늘본상품

오늘 본 상품

없음

위시리스트

  • 보관 내역이 없습니다.
회사명 일프로컴퍼니 주식회사 주소 서울특별시 송파구 송파대로14길 7-10, 2층 201-424호(문정동)
사업자 등록번호 170-87-02915 대표 박덕우 전화 카카오 채널 문의
통신판매업신고번호 2024-서울송파-2805 개인정보 보호책임자 송준혁


Copyright © 일프로컴퍼니 주식회사. All Rights Reserved.

운영시간
평일 : AM 10:00 ~ PM 06:00
점심시간 : PM 12:00 ~ PM 01:00
휴무일 : 토요일, 일요일, 공휴일